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Abstract.  mAbs bd  17, bd 24,  and bd 28 raised 
against bovine cerebral  3,-aminobutyric acid (GABAA)/ 
benzodiazepine receptors were analyzed for their abil- 
ity to detect each of 12 GABAA receptor subunits ex- 
pressed in cultured mammalian cells. Results showed 
that mAb bd  17 recognizes epitopes on both f12 and f13 
subunits while mAb bd 24 is selective for the aj 
subunit of human and bovine, but not of rat origin. 
The latter antibody reacts with the rat c~  subunit car- 
rying an engineered Leu at position four, documenting 
the first epitope mapping of a  GABAA receptor 
subunit-specific mAb.  In contrast to mAbs bd  17 and 
bd 24, mAb bd 28 reacts with all GABAA receptor 
subunits tested but not with a  glycine receptor 
subunit,  suggesting the presence of shared epitopes on 
subunits of GABA-gated chloride channels. 
~ 
-AMINOBUTYRIC ACID (GABA) ~ is the major inhib- 
itory neurotransmitter in the mammalian central ner- 
vous system and gates a chloride-conducting channel 
intrinsic to the GABAA receptor.  GABA-gated  channel ac- 
tivity leading to neuronal hyperpolarization can be modu- 
lated by a variety of compounds, e.g., benzodiazepines and 
barbiturates, some of which are in clinical use (for review, 
see Olsen and Venter,  1986).  The GABAA receptor com- 
plex has  been purified from several  species  (Sigel  et al., 
1983; Schoch et al.,  1984;  Sweetnam et al., 1987; Barnard 
et al., 1987; Bureau and Olsen, 1988) by affinity chromatog- 
raphy  using  the  immobilized benzodiazepine  Ro7-1986/1. 
This receptor is resolved by gel electrophoresis into two ma- 
jor bands with Mr of 50 (termed o0 and 55 kD (termed fl), 
as well as  several  minor bands,  up to an Mr of ~59  kD 
(Fuchs et al.,  1988). 
The  molecular  cloning  of  cDNAs  encoding  GABAA 
receptor subunits showed that these subunits share sequence 
similarities with subunits of both the glycine receptor (Gren- 
ningloh et al., 1987) and the nicotinic acetylcholine receptor 
(Schofield et al.,  1987),  indicating that GABAA receptors 
may well consist of a pentameric arrangement of subunits 
(for  review,  see  Unwin,  1989).  Although  these  cloning 
studies  have  revealed  the  existence  of a  large  family of 
GABAA receptor  subunits,  suggesting  extensive  receptor 
heterogeneity, the exact subunit composition and stoichiom- 
etry of a natural GABAA receptor has yet to be determined. 
In particular,  several  variants of both the ct and fl subunit 
classes are  sequence characterized (Levitan et al.,  1988; 
Ymer et ai.,  1989 a, b;  Pritchett and Seeburg,  1990),  and 
the existence of members of novel subunit classes is docu- 
1. Abbreviation  used in this paper:  GABA, 3,-aminobutyric acid. 
mented (Pritchett et al.,  1989b;  Shivers et al.,  1989).  As a 
consequence similarities in predicted size and the unknown 
extent of glycosylation have hampered the direct assignment 
of gel-resolved receptor polypeptides to cloned subunits. 
Photoaffinity labeling of tritiated receptor ligands as well 
as  mAbs  have been  used  extensively to  characterize  the 
GABAA receptor constituents.  Similarly, these tools have 
been employed in radio- and immunohistochemistry  to char- 
acterize the distribution of this important receptor in the 
mammalian central nervous system (M6hler et al.,  1980; 
H~iring et al., 1985; Schoch et al., 1985; Stephenson et al., 
1986;  Richards et al.,  1987; Sieghart et al.,  1987; de Bias 
et al.,  1988;  Houser et al.,  1988;  Somogyi et al.,  1989). 
However, the molecular heterogeneity of this receptor raises 
the issue of subunit specificity of these antibodies. 
Three mAbs, bd  17, bd 24, and bd 28 developed in one 
of our laboratories (H/iring et al., 1985) have been employed 
successfully  in  the  characterization  and  localization  of 
GABAA receptors  (Schoch et al.,  1984,  1985;  H~ring et 
al., 1985; Richards et al., 1987; Houser et al., 1988; Fuchs 
et al., 1988). Antibody bd 17 binds to a 55-kD polypeptide 
and has been designated as/~-subunit specific (H~iring et al., 
1985). Antibody bd 24 specifically reacts with a 50-kD poly- 
peptide thought to represent a particular oe-subunit. Tritiated 
flunitrazepam photolabels this polypeptide and additionally 
proteins of Mr 53 and 59 kD. These larger proteins as well 
as the 50-kD polypeptide reacted with mAb bd 28, which 
suggested that this antibody is c~ subunit-specific (H~iring et 
al.,  1985;  Fuchs et al.,  1988).  Using an array of cultured 
cells  transiently expressing  12  GABAA receptor  subunits 
and a glycine receptor subunit, we show that mAbs bd 17 and 
bd 24 are highly subunit specific, while mAb bd 28 reacts 
with all  GABAA receptor  subunits tested.  We also deter- 
mined the epitope recognized by mAb bd 24. 
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Transfection of Cultured Cells 
Transformed human embryonic kidney cells 293 (ATCC CRL 1573) (Gor- 
man et al., 1989) were grown at 37°C on coverglass coated with fibronectin 
(25 #g/ttl in PBS) in MEM (Gibco Laboratories, Grand Island, NY) sup- 
plemented with 10% FBS containing 100 U of penicillin (Gibco Laborato- 
ries) and  100 #g of streptomycin (Gibco Laboratories) per ml  in a  5% 
CO.,/95%  air incubator. Exponentially growing cells were trypsinized and 
seeded at 2  x  105 per coverglass in 2 ml of growth medium. The transfec- 
tion was performed by using the calcium phosphate precipitation technique 
(Chen and Okayama,  1987).  The cloned cDNAs of human GABAA recep- 
tor subunits, inserted singly into the eukaryotic expression vector CIS2 
(Pritchett et al., 1988; Gorman et al., 1989) or CDM8 (Ymer et al., 1989 a, 
b),  were used for transfection. The cells were incubated in the presence 
(2 #g/ml) of one or several supercoiled expression plasmids for 12-16 h at 
37°C  under 3%  CO2/97%  air.  The medium was removed, and the cells 
were rinsed twice with culture medium, refed, and incubated in the same 
medium for 24 h at 37°C under 5% CO2/95%  air before beginning the im- 
munological studies. 
Immunocytochemistry 
Medium was removed by aspiration and cells were washed twice with  10 
mM PBS, pH 7.4.  Fixation was performed in  3%  PBS-buffered parafor- 
maldehyde for 5 min. Cells were rinsed twice with PBS and incubated with 
50 mM glycine in PBS. In some cases, cells were permeabilized by the addi- 
tion of 0.3% Triton X-100. After an additional 5 rain,  1% blocking serum 
(Vectastain ABC kit; Vector Laboratories, Burlingame, CA) was applied for 
30 rain. The mAbs were added to cells for 2-3 h in a  1:5 dilution using 
supernatants of cultured  hybridoma cells.  Coverglasses with cells were 
washed gently with PBS and the second biotinylated antiserum (Vectastain 
1:200)  was added for 60  rain.  After washing with PBS the avidin-bio- 
tinylated HRP complex (1:100) was applied for 1.5 h. Cells were rinsed with 
PBS and the reaction was started by incubation in PBS containing 0.05% 
diaminobenzidine/0.03% H202  typically for 5-15  min. To stop this reac- 
tion, cells were again rinsed with PBS. Coverglasses were dipped for a few 
seconds into distilled water and mounted on glass microscope slides with 
Moviol (Hoechst AG, FRG). 
lnsertional Mutagenesis 
The single-stranded M13 nap 18 DNA, containing the cloned rat t~l GABAA 
receptor subunit cDNA, served as a template for insertional oligonucleo- 
tide-mediated DNA synthesis (Adelman et al.,  1983)  in the presence of 
E.  coli polymerase I, Klenow fragment (Boehringer Mannheim Biochemi- 
cals, Indianapolis, IN), and dATP,  dTTP, dGTP, and dCTPaS (Taylor et 
al.,  1985).  The oligonucleotide (5'-TATGGACAGCCCTCCT/'ACAAGAT- 
GAACTT-3')  was complementary to the sequence encoding the amino acid 
residues YGQPSLQDEL, and specified an additional leucine codon at posi- 
tion four of the rat at polypeptide sequence. The mutant detection system 
developed by Eckstein and collaborators (Taylor et al., 1985) was employed 
to minimize screening efforts, using conditions as specified in the protocol 
accompanying the Amersham Corp.  in vitro mutagenesis kit  (Arlington 
Heights, IL).  Resulting MI3 plaques were analyzed by DNA sequencing 
(Sanger et al., 1977). For eukaryotic expression, the cDNA fragments con- 
taining the entire coding regions for the wild type and mutated rat  st 
subunits  were excised with endonucleases Hind 1II and  Pst I  from the 
respective MI3 DNAs after double-strand DNA synthesis primed with the 
lac 17-mer primer (Messing et al.,  1981). These DNA fragments were gel 
purified and cloned into linearized CDM8 vector DNA (Invitrogen, San 
Diego. CA). 
Results 
Single GABAA receptor subunits as well as subunit combi- 
nations can be transiently expressed in cultured mammalian 
cells and the receptors which form in these cells can be readily 
characterized by pharmacological and electrophysiological 
means (Pritchett et al., 1988, 1989a,b; Shivers et al., 1989). 
We have used this system to investigate the specificity of mAbs 
bd  17,  bd 24,  and bd 28  in their detection of 12 GABAA 
receptor subunits. Human embryonic kidney cells grown on 
coverslips were transfected with expression vectors contain- 
ing cloned cDNAs that encode these subunits. After subunit 
expression, fixed, and either permeabilized or nonpermeabi- 
lized cells, were incubated with the antibodies which, in turn, 
were  visualized  by  the  avidin-biotinylated HRP  method. 
Neither untransfected nor mock-transfected 293 cells show- 
ed immunoreactivity with any of the three antibodies (Fig. 
1 a). 
Displaying high specificity, mAb bd 24 reacted only with 
bovine and human c~, subunits (Fig.  1 b), but did not detect 
the  c~,  subunit  of rat origin.  This antibody did  not  react 
with any other c~ subunit variant nor any of the other mem- 
bers of the known GABAA receptor subunit classes. Thus, it 
appears  that mAb bd  24  is  specific for the c~  subunit of 
selected species. 
The mAb bd  17 displayed intensive staining of cells ex- 
pressing  the  rat  /33  subunit  (Fig.  1  c),  a  reproducibly 
weaker reaction with the rat ~2 subunit and no staining with 
rat or human fl~  subunits.  No other GABAA receptor sub- 
unit was recognized by this mAb (Fig. 2). These results con- 
firm that bd 17 is ~-subunit specific as proposed previously 
(H~iring et al.,  1985; Fuchs et al.,  1988). However, mAb bd 
17 is selective for ft., and f13 subunits and fails to react with 
the fit subunit. 
In marked contrast to the specificity of mAbs bd  17 and 
bd 24, mAb bd 28 recognized all six ~  subunits,  although 
with different intensities (Fig. 2), and reacted additionally 
with fl, 3' (Fig.  1 d), and t5 subunits. This nonselectivity of 
mAb bd 28 suggested that it might also bind to subunits of 
the  glycine  receptor,  as  subunits  of GABAA and  glycine 
receptors  are  highly  homologous  (Barnard  et  al.,  1987; 
Grenningloh et al.,  1987; Schofield et al.,  1987). However, 
no  immunocytochemical reaction was  observed  upon ex- 
pression of the 48-kD glycine receptor subunit (Grenningloh 
et al.,  1987), although this subunit was detected by mAb 4 
specific for the glycine receptor (Pfeiffer et al., 1984; Becker 
et al.,  1988). Hence, GABAA receptor subunits may share 
epitopes not present on the glycine receptor. 
In nonpermeabilized cells the antibodies have access only 
to epitopes located at the outer surface of the plasma mem- 
brane.  Under these conditions, mAbs bd 24 and bd 17 did, 
while bd 28 did not, immunoreact with all GABAA receptor 
subunits detected in permeabilized cells. This indicates ex- 
tracellularly located epitopes for mAbs bd 24 and bd  17, 
while the epitope recognized by mAb bd 28 is either intracel- 
lularly located or hidden in a folded structure within the ex- 
traceilular domain. We favor the latter possibility since the 
extracellular domain of the 6 subunit contained in a bacterial 
fusion protein reacted in an ELISA with mAb bd 28 when 
pretreated with Triton X-100 (not shown). However, in sec- 
tions of rat brain, mAb bd 28 did not yield an immunoreac- 
tion even after treatment with detergent (J. G. Richards, per- 
sonal communication). 
Sequence comparisons among the GABA^  receptor sub- 
units failed to reveal likely epitopes for bd  17 and bd 28, 
indicating that features other than primary structure may de- 
termine the reactivity of these antibodies. However, compar- 
ison  of the  ct~  subunit  sequences  from three species  was 
more informative as it revealed very few amino acid substitu- 
tions. In particular, an extra leucine residue occurs in posi- 
tion four of the predicted mature extracellular domain of the 
The Journal  of Cell Biology,  Volume 110, 1990  2044 Figure 1. Immunocytochemistry using different mAbs was performed on 293 cells transiently transfected with GABA^ receptor subunits 
and photographed using phase-contrast optics. Brown staining stems from a DAB precipitate as a result of the peroxidase-coupled reaction. 
(a) Mock-transfected 293 cells do not show any immunoreactivity with the mAb bd 24 (which is shown as representative of all three mAbs); 
(b) human GABAA receptor subunit oft is recognized by mAb Ixl 24; (c) mAb bd  17 reacting with the rat/33  subunit;  and (d) mAb bd 
28 reacting with the human 3'2 GABA^  receptor subunit.  Bar, 30 #m. 
bovine  and  human  versus  the  rat  ot~  subunits.  To  test 
whether this difference correlates with the species selectivity 
of  mAb  bd  24,  we  inserted  the  leucine  residue  by  site- 
directed  mutagenesis  into  the  appropriate  position  of the 
cloned rat a, subunit cDNA.  Upon expression,  the mutated 
rat at  subunit  indeed  reacted with mAb bd 24 (Fig.  3).  As 
predicted,  both  the  normal  and  mutated  rat  cz,  subunits 
were detected by mAb bd 28 in a control experiment. Further 
support that mAb bd 24 specifically recognizes this epitope 
is provided by the positive reaction of the antibody to an im- 
mobilized 14-mer peptide covering amino acid residues  1-14 
of the bovine GABAA  receptor ix,  subunit  (not shown). 
Discussion 
We have tested the specificity of subunit  recognition by the 
three most widely used  mAbs for GABAA receptor charac- 
terization and immunocytochemistry.  Two of these antibod- 
ies displayed a  high specificity towards particular  subunits. 
Thus,  bd  17  is clearly  selective for subunits  of the/3  class, 
detecting/52  and B3,  though  it does not show any reactivity 
towards the B~ subunit  (Figs.  1 and 2).  The latter subunit is 
the  least  expressed  among  the  /3  subunits  in  the  CNS  as 
judged by Northern analysis (Ymer et ai.,  1989 b). Sequence 
comparisons  among the  three/3  subunits  did  not  give any 
clues as to which epitope mediates 132 and/53  subunit recog- 
nition  by  mAb bd  17.  In brain  sections,  bd  17  recognizes 
GABAA  receptors  with  the  pattern  of epitope  distribution 
Figure 2.  Differential  reactiv- 
ity of mAbs bd 17, bd 24, and 
bd  28  towards  12  GABAA 
receptor  subunits  and  a  gly- 
cine  receptor  subunit.  The 
different shadings of each field 
represent the immunoreactivi- 
ties  of  mAbs  with  specific 
GABAA  receptor  subunits. 
The following  GABAA recep- 
tor subunits  from the follow- 
ing  species  were  tested:  a~, 
rat, bovine,  human  (r,  b,  h); 
~2,  h;  or3, h;  a4,  b  (Ymer et 
ai.,  1989a);  ~5,  r  (Khrest- 
chatisky et al., 1989; Pritchett 
and  Seeburg,  1990);  ~6,  b; 
BJ, r and h;/32,  r; ~3, r; 3'~, h; 
3'2, h; (5, r; Gly 48K, r and h. 



























































































































































































































































































































































































































































































































































































































































 often corresponding to the distribution of radioligand bind- 
ing sites (Schoch et al.,  1985; Richards et al.,  1987). Thus, 
in the absence of data from high-resolution immunocyto- 
chemistry, the f12 and/or f13 subunits seem frequently com- 
ponents of natural GABAA receptors. 
Antibody bd 24 presented the highest selectivity because 
it reacted solely with the a~  subunit of human and bovine 
origin but failed to react with rat ot~  (Figs.  1 and 2).  This 
species specificity has been noticed previously (H/iring et 
al.,  1985).  However,  the  selectivity for at  excluding  all 
other a  subunits, documented here, had not been previously 
appreciated.  Currently,  six  ~  subunits  are  characterized 
(Schofield et al.,  1987,  1989; Ymer et al.,  1989a; Khrest- 
chatisky et al.,  1989; Pritchett and Seeburg, 1990) that dis- 
play ~70% sequence homology in their extracellular domain 
(>80%). Hence the selectivity ofmAb bd 24 makes this anti- 
body a particularly useful tool to study otz subunit-contain- 
ing GABAA receptors. The latter receptors are highly ex- 
pressed  in  many parts  of the mammalian  central  nervous 
system and are constituents of the pharmacologically impor- 
tant BZ I type of GABAA/benzodiazepine receptors (Pritch- 
ett et al.,  1989a). In sections of brain from several species, 
the epitope distribution for mAb bd 24 is very similar to that 
of mAb bd 17 (Schoch et al.,  1985; Richards et al.,  1988; 
Somogyi et al.,  1989). Thus, the natural GABAA/benzodi- 
azepine receptors frequently contain o~  subunits  in  some 
combination with/3z and/or f13 subunits. 
In stark contrast to mAbs bd  17 and bd 24, mAb bd 28 
is indiscriminate in its binding to all GABAA receptor sub- 
units tested (Figs.  1 and 2). Interestingly, it reacts with sub- 
units of all classes including the fl and t5 classes having low 
homology to ot subunits.  Although mAb bd 28 reacts with 
all subunits, the extent of this reaction is not as uniform as 
oe4, fl~, and f13 subunits  are less intensively stained.  Such 
lower reactivity could be due to a reduced expression effi- 
ciency of these subunits.  While we cannot investigate this pos- 
sibility due to the lack of subtype-specific antibodies,  we 
would like to stress that DNA constructs for expression of the 
fl~ and a4 subunits injected into Xenopus oocyte nuclei lead 
to  large  chloride  currents  upon  superfusion  with  GABA 
(Ymer et al.,  1989a). The lack of selectivity of mAb bd 28 
is unexpected considering earlier findings in which bd 28 
reacted mainly  with  ot  subunit  proteins  in  Western  blots 
(H~iring et al., 1985; Fuchs et al., 1988). The epitope recog- 
nized by this antibody may not be preserved to the same ex- 
tent in all subunits under Western blot conditions. 
As  for  mAb  bd  17,  a  sequence  search  among  GABAA 
receptor subunits for a common epitope to account for mAb 
bd 28 recognition was  unsuccessful. Our finding that mAb 
bd 28 does not react with the 48-kD subunit of the glycine 
receptor although subunits of both receptors share '~35 % se- 
quence  similarity points  to an  epitope unique  to GABAA 
receptor subunits (Barnard et al.,  1987; Grenningloh et ai., 
1987;  Schofield  et  al.,  1987).  This  extent  of  sequence 
similarity is also found between members of different classes 
of GABAA receptor subunits.  A successful epitope charac- 
terization was achieved in the case of mAb bd 24 where a 
leucine residue present in  the human and bovine o~  sub- 
units, but absent in the rat homologue, was identified as an 
essential part of the specific epitope recognized by this anti- 
body (Fig.  3). 
The present characterization should greatly aid in the in- 
terpretation of immunocytochemical results obtained with 
the use of these mAbs. Our present studies underscore the 
importance  of determining  the  specificities of antibodies 
directed against  subunits of ligand-gated ion channels.  As 
these subunits are members of the large gene family with 
significant similarity, the reactivity towards several subunits 
of antibodies once thought to be subunit specific becomes a 
likely possibility.  Hence,  an  immunomethod that  utilizes 
cells expressing an array of related subunits is a convenient 
and necessary tool to characterize such antibodies. Further- 
more, modifications of this method should also permit an in- 
vestigation into intracellular processing assembly and trans- 
port  (Hurtley  and  Helenius,  1989)  as  well  as  receptor 
insertion into the cell surface of subunits expressed singly or 
in combination with others. 
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